<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150715023216N16</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-06</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>A comparative study of the local effect of Aloe Vera gel with cold and warm compress on  the lower leg after coronary artery bypass surgery</public_title>
      <acronym></acronym>
      <scientific_title>A comparative study of the local effect of Aloe Vera gel with cold and warm compress on ecchymosis of the lower leg after coronary artery bypass surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72489</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The number of 60 patients who are candidates for coronary artery bypass surgery in Chamran Hospital according to the entry criteria, with a gradual method based on the order of referrals with random allocation (using a coin toss) in group A (local effect of aloe vera gel) or group B ( use of cold and warm compresses) or control are placed.
Then, the subjects in each group are randomly selected in order to determine the right or left leg for intervention, using two envelopes containing number 1 (intervention) and number 2 (control) inside a box, and based on the desired number, The surgical incision site of the patient's legs is allocated in the intervention leg with aloe vera and the control leg.
The same procedure is done for the patient in group B.
In groups A and B, one foot of the patient is treated and the other foot is considered as control.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Ecchymosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The first stage of intervention in group A (local effect of aloe vera gel) is performed before dressing the wound in the operating room. In the opposite leg, routine intervention is performed, i.e. washing the wound with normal saline and dressing with sterile gauze and adhesive and bandaging. This procedure continues for 6 days. Photographs are taken of the desired position (legs of both legs) (days 2, 5, 7, 10 and 30). On the 10th and 30th days, in the office of Dr. Mohsen Mir Mohammad Sadeghi, photographs of the patient's legs are taken and the area of ​​hemorrhage is calculated using image j software.The aloe vera gel used in this research is prepared by Reyhan Naqsh Jahan Pharmaceutical Company based on the United States Pharmacopoeia (USP), which is packed in sterile containers under sterile conditions and in compliance with hygiene precautions with sterile gloves. Intervention with aloe vera gel in The first to sixth days are done in the inpatient departments. In group A, the first intervention stage is performed in the operating room by Dr. Mohsen Mir Mohammad Sadeghi's dedicated assistant with sterile aloe vera gel that has been prepared in advance on the affected leg, and then dressing is performed with sterile gauze, glue, and bandaging. Dressing with sterile gauze, glue and bandaging is performed on the control legThen, on a daily basis, standard methods of surgical wound care, such as washing with normal saline and performing sterile dressings once a day, elastic bandages for both legs of patients, are performed by nurses working in the special care and surgery department. Both groups A and B, one leg of the patient is treated and the other leg is considered as control. Intervention 2: In group B (use of hot and cold compresses), one of the legs is placed under a cold compress in the first 48 hours after the surgery, and then on the third to sixth days of the surgery, a warm compress is applied, and in the opposite leg, a routine intervention, i.e. washing the wound with Normal saline serum and dressing is done with sterile gauze and adhesive and bandaging. This procedure continues for 6 days. Photographs are taken of the desired position (legs of both legs) (days 2, 5, 7, 10 and 30). On the 10th and 30th days, in the office of Dr. Mohsen Mir Mohammad Sadeghi, photographs are taken of the patient's legs and the area of ​​hemorrhage is calculated using image j software.Intervention with cold compresses in the inpatient wards, on the first two days of surgery, a gel pack (HEPSUN) that has been placed in the freezer an hour before is placed around the wound with a gauze cover for 10 minutes, and in the next four days in the inpatient wards ( Day 3, 4, 5, 6) A warm compress in the form of a jelly pack (HEPSUN) that we have previously placed in the microwave for one minute or in boiling water for 10 minutes, is placed in a cloth bag and placed around the wound on the control leg. Dressing is done with sterile gauze, glue and bandaging.On a daily basis, standard methods of surgical wound care, such as washing with normal saline and performing sterile dressings once a day, elastic bandages for both legs of patients are performed by nurses working in the special care and surgery department. Both groups A and B, one leg of the patient is treated and the other leg is considered as control. Intervention 3: Control group:  In this research, the control group is the same leg opposite to the intervention leg in intervention number 1 and 2. In both groups A and B, based on randomization, using a box, one leg of the intervention patient and the other leg It is considered as the control leg. In the control group, the routine intervention is washing the wound with normal saline and dressing with sterile gauze, glue and bandaging. This procedure continues for 6 days. Photographs are taken of the target position (legs of both legs) (days 2, 5, 7, 10 and 30) and the area of ​​hemorrhage is calculated using image j software.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ahmad Gadami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>HezarJerib Street , Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 7583</telephone>
        <email>ghadami@mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Shahriar Panah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>HezarJerib Street, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 3028</telephone>
        <email>kosarhasan.shahryar06@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Informed and written consent to participate in the study
Coronary bypass surgery
removal of vascular grafts from both legs</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>history of skin disease
emergency surgery
allergy to aloe vera
drug use or continuous alcohol or cigar use
history of vascular disease such as Raynaud's, Berger's, etc.
history of drug, food or allergy
coagulopathy or the need to take anti-coagulant drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The first stage of intervention in group A (local effect of aloe vera gel) is performed before dressing the wound in the operating room. In the opposite leg, routine intervention is performed, i.e. washing the wound with normal saline and dressing with sterile gauze and adhesive and bandaging. This procedure continues for 6 days. Photographs are taken of the desired position (legs of both legs) (days 2, 5, 7, 10 and 30). On the 10th and 30th days, in the office of Dr. Mohsen Mir Mohammad Sadeghi, photographs of the patient's legs are taken and the area of ​​hemorrhage is calculated using image j software.The aloe vera gel used in this research is prepared by Reyhan Naqsh Jahan Pharmaceutical Company based on the United States Pharmacopoeia (USP), which is packed in sterile containers under sterile conditions and in compliance with hygiene precautions with sterile gloves. Intervention with aloe vera gel in The first to sixth days are done in the inpatient departments. In group A, the first intervention stage is performed in the operating room by Dr. Mohsen Mir Mohammad Sadeghi's dedicated assistant with sterile aloe vera gel that has been prepared in advance on the affected leg, and then dressing is performed with sterile gauze, glue, and bandaging. Dressing with sterile gauze, glue and bandaging is performed on the control legThen, on a daily basis, standard methods of surgical wound care, such as washing with normal saline and performing sterile dressings once a day, elastic bandages for both legs of patients, are performed by nurses working in the special care and surgery department. Both groups A and B, one leg of the patient is treated and the other leg is considered as control.</i_keyword>
      <i_keyword>In group B (use of hot and cold compresses), one of the legs is placed under a cold compress in the first 48 hours after the surgery, and then on the third to sixth days of the surgery, a warm compress is applied, and in the opposite leg, a routine intervention, i.e. washing the wound with Normal saline serum and dressing is done with sterile gauze and adhesive and bandaging. This procedure continues for 6 days. Photographs are taken of the desired position (legs of both legs) (days 2, 5, 7, 10 and 30). On the 10th and 30th days, in the office of Dr. Mohsen Mir Mohammad Sadeghi, photographs are taken of the patient's legs and the area of ​​hemorrhage is calculated using image j software.Intervention with cold compresses in the inpatient wards, on the first two days of surgery, a gel pack (HEPSUN) that has been placed in the freezer an hour before is placed around the wound with a gauze cover for 10 minutes, and in the next four days in the inpatient wards ( Day 3, 4, 5, 6) A warm compress in the form of a jelly pack (HEPSUN) that we have previously placed in the microwave for one minute or in boiling water for 10 minutes, is placed in a cloth bag and placed around the wound on the control leg. Dressing is done with sterile gauze, glue and bandaging.On a daily basis, standard methods of surgical wound care, such as washing with normal saline and performing sterile dressings once a day, elastic bandages for both legs of patients are performed by nurses working in the special care and surgery department. Both groups A and B, one leg of the patient is treated and the other leg is considered as control.</i_keyword>
      <i_keyword>Control group:  In this research, the control group is the same leg opposite to the intervention leg in intervention number 1 and 2. In both groups A and B, based on randomization, using a box, one leg of the intervention patient and the other leg It is considered as the control leg. In the control group, the routine intervention is washing the wound with normal saline and dressing with sterile gauze, glue and bandaging. This procedure continues for 6 days. Photographs are taken of the target position (legs of both legs) (days 2, 5, 7, 10 and 30) and the area of ​​hemorrhage is calculated using image j software.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Average area of ​​Ecchymosis. Timepoint: Days 2, 5, 7, 10 and 30 after coronary artery bypass surgery. Method of measurement: The program for determining the area of ​​j image and A30s phone camera.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-04</approval_date>
        <contact_name>Ethical Committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hezarjerib street, Isfahan,Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
